The potential impact of new National Osteoporosis Foundation guidance on treatment patterns
Explore this paper's citation graph
Summary
An analysis of National Health and Nutrition Examination Survey III data describes the prevalence of risk factors for osteoporosis and the proportions of men and postmenopausal women age 50 years and older who are candidates for treatment to lower fracture risk, according to the new FRAX®-based National Osteoporotic Foundation Clinician's Guide.
- Type
- article
- Published
- 2009-08-24
- Cited by
- 106
- References
- 28
- OpenAlex
- https://openalex.org/W1978677270
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:35249060
Keywords
Medicine, National Health and Nutrition Examination Survey, Osteoporosis, FRAX, Postmenopausal women
References
- What is Evidence-Based Medicine and Why Should it be Practiced?
- Early discontinuation of treatment for osteoporosis.
- Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004.
- Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.
- Updated Data on Proximal Femur Bone Mineral Levels of US Adults
- Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025
- Serum 25-hydroxyvitamin D status of the US population: 1988–1994 versus 2000–2004
- Potential risk factors for development of postmenopausal osteoporosis — Examined over a 12-year period
- Osteoporosis Management in a Medicaid Population after the Women's Health Initiative Study
- Longitudinal Trends in Use of Bone Mass Measurement Among Older Americans, 1999–2005
- Issues in design, measurement, and analysis for menopause research.
- Trends in hospital care for hip fractures
- Undertreatment of osteoporosis in men with hip fracture.
- Updated fracture incidence rates for the US version of FRAX®
- Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification.
- Toward the 'tipping point': decision aids and informed patient choice.
- Calcium Supplement and Bone Medication Use in a US Medicare Health Maintenance Organization
- Estimates of the Proportion of Older White Women Who Would Be Recommended for Pharmacologic Treatment by the New U.S. National Osteoporosis Foundation Guidelines
- Quality control of bone densitometry in a national health survey (NHANES III) using three mobile examination centers
- Secular trends in hip fracture incidence and recurrence
Cited by
- Patterns of Pharmacological Treatment for Osteoporosis Among Patients Qualified for Pharmacotherapy According to the National Osteoporosis Foundation Guidelines
- The Short Term Impact of a Mediterranean-Style Diet on Bone Markers in Post-Menopausal Women
- FRAX-based assessment and intervention thresholds—an exploration of thresholds in women aged 50 years and older in the UK
- Official Positions for FRAX® clinical regarding biochemical markers from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
- A Guide to Improving the Care of Patients with Fragility Fractures, Edition 2
- Contribution of Lumbar Spine BMD to Fracture Risk in Individuals With T‐Score Discordance
- Underestimated Fracture Probability in Patients with Unilateral Hip Osteoarthritis as Calculated by FRAX®
- FRAX Predicts Fracture Risk in Kidney Transplant Recipients
- Novel methods to evaluate fracture risk models
- Independent clinical validation of a Canadian FRAX tool: Fracture prediction and model calibration
- An evaluation of the NICE guidance for the prevention of osteoporotic fragility fractures in postmenopausal women
- Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry
- Predicting Hip and Major Osteoporotic Fractures Using Administrative Data
- A Review of Osteoporosis Diagnosis and Treatment Options in New and Recently Updated Guidelines on Case Finding Around the World
- Osteoporosis and Milk Intake among Korean Women in California: Relationship with Acculturation to U.S. Lifestyle
- Fracture risk assessment in Latin America: is Frax™ an adaptable instrument for the region?
- Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice
- Does osteoporosis therapy invalidate FRAX for fracture prediction?
- Estimating bisphosphonate use and fracture reduction among US women aged 45 years and older, 2001–2008
- Defining Ethnic and Racial Differences in Osteoporosis and Fragility Fractures
Related papers
- ОЦЕНКА РИСКА ПЕРЕЛОМОВ С ИСПОЛЬЗОВАНИЕМ МОДЕЛИ FRAX® (РЕТРОСПЕКТИВНОЕ ДЕСЯТИЛЕТНЕЕ ИССЛЕДОВАНИЕ)
- FRAX First – Pragmatic Approach in Resource Poor Settings
- The role of bone mineral density in therapeutic decision-making using the Fracture Risk Assessment Tool (FRAX): a sub-study of the Taiwan OsteoPorosis Survey (TOPS)
- Official Positions for FRAX® Bone Mineral Density and FRAX® simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
- Adjusting FRAX® on TBS for identification of subjects at high risk of fractures.
- [Efficacy of densitometry and fracture risk assessment tool FRAX in making therapeutic decisions in osteoporosis--a study on female patients of university of medical sciences endocrinology outpatient clinic].
- Fracture risk assessment tool(FRAX) for osteoporosis diagnosis and treatment
- The Study of Relationship Between Life Habits of Postmenopausal Women and Osteoporosis